Production of gelatin-degrading matrix metalloproteinases ('type IV collagenases') and inhibitors by articular chondrocytes during their dedifferentiation by serial subcultures and under stimulation by interleukin-1 and tumor necrosis factor alpha
- PMID: 1653026
- DOI: 10.1016/0167-4889(91)90020-x
Production of gelatin-degrading matrix metalloproteinases ('type IV collagenases') and inhibitors by articular chondrocytes during their dedifferentiation by serial subcultures and under stimulation by interleukin-1 and tumor necrosis factor alpha
Abstract
The gelatin-degrading matrix metalloproteinase (MMP) activities and their inhibitors produced by rabbit articular chondrocytes have been characterized by gel substrate analysis ('zymography') after electrophoresis on non-reducing sodium dodecyl sulfate-polyacrylamide gels containing gelatin. Differentiated chondrocytes in confluent primary culture produced constitutively only one gelatinase which presented the main characteristics of proMMP-2 ('72 kDa type IV procollagenase'). It had an apparent Mr of 66,000 (unreduced), which was partially or totally converted to 61,000 by, respectively, trypsin or APMA treatment; exogenous TIMP (tissue inhibitor or metalloproteinases) inhibited the conversion triggered by APMA but not that induced by trypsin. This proMMP-2 was also the predominant gelatinase found, together with its 61 kDa activation product, in extracts of articular cartilage. Differentiated chondrocytes simultaneously produced MMP inhibitors which on reverse zymograms were distributed over two bands with Mr of 27,500 and 20,400, resistant to both pH 2 and 100 degrees C, corresponding, respectively, presumably, to TIMP and TIMP-2. Interleukin-1 (IL1) and tumor necrosis factor alpha (TNF alpha) did not affect the production of the proMMP-2 nor of the two species of TIMP. However, IL1 induced the coordinated production of 91 and 55 kDa gelatinases. The 91 kDa activity is likely to correspond to proMMP-9. It could be converted to a 81 kDa gelatinase by trypsin or APMA treatment, in a process that was inhibited in both cases by exogenous TIMP. The 55 kDa gelatinolytic activity most probably represents the sum of the activities of proMMP-1 (procollagenase) and proMMP-3 (prostromelysin). It was sequentially converted to lower size forms (49 to 35 kDa) by either trypsin or APMA; that conversion was inhibited by TIMP, with the exception, however, of the first steps (from 55 to 49, then to 42 kDa) induced by trypsin. The 55 kDa and its conversion forms were all active on both gelatin and casein. TNF alpha did also stimulate the production of proMMP-9, although less efficiently than IL1, but it did not induce, or very poorly, that of the 55 kDa proMMP-1/proMMP-3 activity. Low levels of proMMP-9 and of its 81 kDa product of activation were also found in extracts of cartilage. With increasing passage number and cell dedifferentiation, confluent chondrocytes produced increasing amounts of proMMP-2 and of the two species of TIMP. A spontaneous low production of proMMP-9 and proMMP-1/proMMP-3 was only occasionally observed in cultures of dedifferentiated chondrocytes, accompanying a spontaneous low production of procollagenase.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Modulation by interleukin 1 and tumor necrosis factor alpha of production of collagenase, tissue inhibitor of metalloproteinases and collagen types in differentiated and dedifferentiated articular chondrocytes.Biochim Biophys Acta. 1990 May 22;1052(3):366-78. doi: 10.1016/0167-4889(90)90145-4. Biochim Biophys Acta. 1990. PMID: 2162214
-
Production of collagens, collagenase and collagenase inhibitor during the dedifferentiation of articular chondrocytes by serial subcultures.Biochim Biophys Acta. 1990 Mar 9;1051(3):266-75. doi: 10.1016/0167-4889(90)90132-w. Biochim Biophys Acta. 1990. PMID: 2155668
-
Characterization and identification of proteinases and proteinase inhibitors synthesized by temporomandibular joint disc cells.J Dent Res. 1995 Jun;74(6):1328-36. doi: 10.1177/00220345950740061301. J Dent Res. 1995. PMID: 7629341
-
Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells.Biochem J. 1992 Jul 15;285 ( Pt 2)(Pt 2):603-11. doi: 10.1042/bj2850603. Biochem J. 1992. PMID: 1379048 Free PMC article.
-
Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) is induced in rabbit articular chondrocytes by cotreatment with interleukin 1 beta and a protein kinase C activator.Exp Cell Res. 1992 Aug;201(2):245-9. doi: 10.1016/0014-4827(92)90271-9. Exp Cell Res. 1992. PMID: 1322311
Cited by
-
Nanohydroxyapatite-Coated Titanium Surface Increases Vascular Endothelial Cells Distinct Signaling Responding to High Glucose Concentration.J Funct Biomater. 2023 Mar 28;14(4):188. doi: 10.3390/jfb14040188. J Funct Biomater. 2023. PMID: 37103278 Free PMC article.
-
The Action of Angiocrine Molecules Sourced from Mechanotransduction-Related Endothelial Cell Partially Explain the Successful of Titanium in Osseointegration.J Funct Biomater. 2023 Aug 8;14(8):415. doi: 10.3390/jfb14080415. J Funct Biomater. 2023. PMID: 37623660 Free PMC article.
-
Prevention of acute autoimmune encephalomyelitis and abrogation of relapses in murine models of multiple sclerosis by the protease inhibitor D-penicillamine.Inflamm Res. 1995 Dec;44(12):529-34. doi: 10.1007/BF01757357. Inflamm Res. 1995. PMID: 8788233
-
Zirconia stimulates ECM-remodeling as a prerequisite to pre-osteoblast adhesion/proliferation by possible interference with cellular anchorage.J Mater Sci Mater Med. 2018 Mar 26;29(4):41. doi: 10.1007/s10856-018-6041-9. J Mater Sci Mater Med. 2018. PMID: 29582191
-
Modulation of proteases and their inhibitors in immortal human osteoblast-like cells by tumor necrosis factor-alpha in vitro.Inflammation. 1994 Jun;18(3):243-65. doi: 10.1007/BF01534267. Inflammation. 1994. PMID: 8088923
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous